Programmable Biochips: DNA Storage Is Replacing Silicon-Based Memory

Programmable Biochips: DNA Storage Is Replacing Silicon-Based Memory

In October 2027, Microsoft Research and the MIT Media Lab jointly announced that their co-developed BioCore line of biological storage chips has officially entered commercial production. The first BioCore-1TB modules have shipped to Amazon Web Services, Google Cloud, and Alibaba Cloud for cold-data storage use cases. This marks the first time in the seven-decade history of silicon-based semiconductor storage that a fundamentally different alternative has reached the market.

Why DNA Storage Matters

Global data volume is growing at roughly 25% per year. According to IDC projections, total worldwide data will reach approximately 175 zettabytes by 2028. Conventional storage media are hitting physical limits — NAND flash processes are approaching 3nm, and further shrinkage invites serious electron tunneling effects and reliability concerns. Tape storage is cheap but painfully slow, and its mechanical components limit longevity.

DNA molecules have an inherent advantage in information density. One gram of DNA can theoretically store about 215 petabytes (215 million GB) of data and, under proper conditions, remain stable for centuries — data encoded into DNA by a Harvard team in 2012 was still fully readable in 2023. The challenge has always been write/read speed and cost.

"The real breakthroughs of the past decade aren't in storage density — they're in encoding/decoding speed and cost," said Lulu Qian, MIT bioengineering professor and BioCore's lead scientist, in an interview. "In 2025, we brought DNA synthesis costs from 10 cents per base to 0.003 cents, and read speeds from a few kilobytes per day to 200 megabytes per second. This is an engineering victory, not a fundamental science breakthrough."

BioCore Architecture Explained

The BioCore-1TB module is roughly the size of a 2.5-inch hard drive (100mm × 70mm × 15mm), but its internal structure bears no resemblance to a conventional storage device.

At the module's core is a microfluidic chip integrating 4,096 independent DNA synthesis/read channels. Each channel contains approximately 50 microliters of reaction fluid in which encoded synthetic DNA fragments are suspended. For writes, BioCore's dedicated controller converts binary data into a quaternary base sequence (A, T, C, G) and uses electrochemical synthesis to inscribe data into DNA molecules segment by segment. For reads, nanopore sequencing technology scans the DNA strands and converts them back into digital signals in real time.

Key specifications:

• Storage density: ~10 TB/cm³ — 1,000x that of conventional 3D NAND
• Write speed: 200 MB/s (sequential), sufficient for cold-data archiving
• Read speed: 150 MB/s (sequential), roughly 300x faster than tape
• Data retention: estimated at over 500 years under lab conditions
• Power consumption: near-zero standby (no power needed to maintain data); write energy is approximately 1/100 that of an equivalent-capacity SSD
• Rewrite cycles: DNA molecules can endure approximately 100 full synthesis-degradation cycles

"BioCore isn't here to replace your SSD," said Karin Strauss, head of storage systems at Microsoft Research, at the launch. "It's positioned for cold data — data that's written once and rarely read again: medical imaging, satellite telemetry, genomic databases. That data accounts for over 60% of global volume today, yet it consumes enormous amounts of power and floor space."

Commercial Deployment and Pricing

BioCore-1TB's first customers are the three major cloud providers, primarily for their archival storage tiers. Amazon AWS has announced it will offer a BioCore-backed option within S3 Glacier, projecting storage costs roughly 40% below current tape-based solutions.

Direct sales channels for enterprises and research institutions are expected to open in Q2 2028. Microsoft's reference pricing: approximately $1,200 per BioCore-1TB module, translating to roughly $1.20 per TB — well below enterprise HDD at ~$15/TB and tape at ~$4/TB (both inclusive of maintenance costs). However, BioCore requires a dedicated read/write controller priced at approximately $8,000.

For data center deployment, BioCore modules operate in a temperature-controlled (4°C) and humidity-stabilized environment, which aligns reasonably well with existing data center cooling infrastructure. Microsoft has completed the first BioCore rack deployment at its Ashburn, Virginia data center — a single rack delivers 1.2 petabytes of capacity and occupies just 1/50 the floor space of an equivalent tape library.

Technical Challenges and Risks

BioCore's biggest technical limitation is random-access latency. Unlike SSDs' microsecond-level latency, BioCore's random read latency sits around 500 milliseconds, because the microfluidic system must locate a specific DNA fragment pool and initiate a sequencing reaction. This makes BioCore entirely unsuitable for hot or warm data scenarios today.

Security introduces a novel threat model. An attacker could theoretically steal data by physically extracting DNA fragments, and unlike digital keys, DNA fragments cannot be remotely destroyed. Professor Qian's team is developing "self-destructing DNA" — synthetic molecules that automatically degrade when triggered by specific environmental signals — but the technology remains in the lab.

A longer-term concern is the chemical reagents required for DNA synthesis. Large-scale BioCore production demands substantial quantities of organophosphorus reagents and nucleotide raw materials, with supply chains concentrated among a handful of bioreagent firms. A supply chain disruption could sharply curtail BioCore output. Additionally, new industry standards are needed for the safe disposal of spent DNA storage modules to prevent biological contamination.

On a broader level, DNA storage could intensify the "data immortality" problem. When data can persist for 500 years or more, how is an individual's "right to be forgotten" upheld? The European Data Protection Board has indicated it is studying GDPR supplementary provisions specific to biological storage media.

Looking Ahead: From Cold Storage to General-Purpose

The BioCore team's long-term goal is to extend DNA storage from cold data into warm-data territory. The next-generation BioCore-2 module, targeted for 2029, aims to bring random-read latency below 50 milliseconds and push write speeds to 1 GB/s. If achieved, DNA storage would directly challenge SSDs in the warm-data tier.

Academic researchers are exploring even more radical approaches. Yaniv Erlich's team at Columbia University is investigating "living storage" — encoding data into the genomes of living cells, using cellular self-replication for automatic backup and distributed storage. The technology currently achieves only kilobyte-scale storage at lab scale, but the concept has already sparked philosophical debates about "data life."

BioCore's commercialization is a milestone for the data storage industry. Whether or not DNA storage ultimately displaces silicon-based solutions, it has already proven one thing: the next paradigm shift in computing may not come from shrinking transistors further, but from borrowing nature's own information-encoding playbook.